NCT07502768
- Conditions
- Disease Attributes, Extranodal NK/T-cell Lymphoma, Lymphoma, +10 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Clinical trial condition
Extranodal NK/T-cell Lymphoma
Explore clinical trials studying Extranodal NK/T-cell Lymphoma. Study availability and eligibility vary by location and protocol.
11 public trials
2 recruiting studies
Extranodal NK/T-cell Lymphoma trial results
NCT06824883
- Conditions
- Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
- Locations
-
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
Not Yet Recruiting
Clinical and Biological Cohort Study of EBV-Positive T/NK-Cell Lymphoproliferative Diseases
NCT07727083
- Conditions
- Aggressive NK-cell Leukemia, DNA Virus Infections, Epstein-Barr Virus Infections, +24 more
- Locations
-
- Fudan University Shanghai Cancer Center Shanghai, Shanghai Municipality, China
Not Yet Recruiting
BRIDGE-NK: Immunotherapy Versus Chemotherapy Induction Followed by Autologous HSCT in Advanced NKTCL
NCT07678229
- Conditions
- DNA Virus Infections, Epstein-Barr Virus Infections, Extranodal NK/T-cell Lymphoma, +10 more
- Locations
-
- Fudan University Shanghai Cancer Center, Shanghai, Shanghai Municipality, China
Not Yet Recruiting
Study of Sugemalimab (or Placebo) Plus PGemOx Regimen in Participants With Extranodal NK/T-Cell Lymphoma
NCT05700448
- Conditions
- Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
- Locations
-
Not specified
Not Yet Recruiting
Selinexor Combined With Reduced-Dose Radiotherapy For Early-Stage Extranodal NK/T-Cell Lymphoma
NCT07554482
- Conditions
- Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
- Locations
-
- Beijing Tongren Hospital, Capital Medical University Beijing, China
NCT07385989
- Conditions
- Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
- Locations
-
Not specified
Completed
Study of BGB-A317 in Participants With Relapsed or Refractory Mature T- and NK-cell Neoplasms
NCT03493451
- Conditions
- ALK-Positive Anaplastic Large Cell Lymphoma, ALK-negative Anaplastic Large Cell Lymphoma, Adult Nasal Type Extranodal NK/T-cell Lymphoma, +36 more
- Locations
-
- British Columbia Cancer Agency the Vancouver Centre Vancouver, British Columbia, Canada
- Peking University Third Hospital Beijing, Beijing Municipality, China
- Beijing Hospital Beijing, Beijing Municipality, China
- Peking Union Medical College Hospital Beijing, Beijing Municipality, China
NCT03246750
- Conditions
- Extranodal NK/T-cell Lymphoma, Lymphoma, Lymphoma, Extranodal NK-T-Cell, +4 more
- Locations
-
- King Chulalongkorn Memorial Hospital Bangkok, Thailand
Active, Not Recruiting
A Study of IMC-001 in Subjects With Relapsed or Refractory Extranodal NK/T Cell Lymphoma, Nasal Type
NCT04414163
- Conditions
- Extranodal NK/T-cell Lymphoma, Extranodal NK/T-cell Lymphoma, Nasal Type, Lymphoma, +5 more
- Locations
-
- Chonnam National University Hwasun Hospital Gwangju, South Korea
- Asan Medical Center Seoul, South Korea
- Samsung Medical Center Seoul, South Korea
- Seoul National University Hospital Seoul, South Korea